Evidence map›Paper›PMID 38814079›Full record

ArticleMicrobiology spectrum2024

The

Clara M Herrera, Eleanor McMahon, Danielle L Swaney, Jessica Sherry, Khavong Pha, Kathleen Adams-Boone, Jeffrey R Johnson, Nevan J Krogan, Meredith Stevers, David Solomon and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Infection and immunity · 2026
    Article
  2. Review
4 · The record

Corrections and comments

  • Update of
    The2024
5 · Who and what money

Authors and funding

12 authors.

Clara M HerreraDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.
Eleanor McMahonDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.
Danielle L SwaneyDepartment of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, USA.
Jessica SherryDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.
Khavong PhaDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.
Kathleen Adams-BooneDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.
Jeffrey R JohnsonDepartment of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, USA.
Nevan J KroganDepartment of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0003-4902-337X
Meredith SteversDepartment of Pathology, University of California San Francisco, San Francisco, California, USA.
David SolomonDepartment of Pathology, University of California San Francisco, San Francisco, California, USA.
Cherilyn ElwellDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0001-7702-3938
Joanne EngelDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0002-2168-9711

Funding

GENETICS OF EUCARYOTIC AND PROCARYOTIC ORGANISMST32GM007810 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ASHRAFI, KAVEH, NARLIKAR, GEETA J · 1985 to 2020
$15.1M
Microbial Pathogenesis and Host DefenseT32AI060537 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joanne N. Engel · 2004 to 2026
$6.5M
Recognition of Bacterial Flagellin by MacrophagesR01AI052286 · NIAID · SEATTLE BIOMEDICAL RESEARCH INSTITUTE · PI ADEREM, ALAN A · 2002 to 2011
$4.2M
Decoding the Chlamydia inclusion membrane protein-host protein interactomeR01AI122747 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ENGEL, JOANNE N., KAAKE, ROBYN MIDORI · 2016 to 2020
$3.1M
Inclusion membrane protein (Inc) modulation of the innate immune response to Chlamydia trachomatisR56AI152526 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ENGEL, JOANNE N., SWANEY, DANIELLE L · 2020 to 2020
$803k
Remodeling of the Host Ubiquitin Landscape by Chlamydia trachomatisF32AI133902 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PHA, KHAVONG · 2017 to 2019
$179k
Decoding the interaction of the Chlamydia secreted effector CT192 with host dynactinF31AI133951 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SHERRY, JESSICA · 2017 to 2019
$117k
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R56AI152526HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) RO1AI122747NIAID NIH HHS F31 AI133951NIAID NIH HHS F32 AI133902NIAID NIH HHS R01 AI052286NIAID NIH HHS R01 AI122747NIAID NIH HHS R56 AI152526NIAID NIH HHS T32 AI060537NIGMS NIH HHS T32 GM007810NIH HHS F31 AI133951NIH HHS F31 AI52286NIH HHS F32 AI133902NIH HHS T32 AI 60537NIH HHS T32 GM007810UCSF Discovery Fellows program
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bacterial ProteinsChlamydia InfectionsChlamydia trachomatisHost-Pathogen InteractionsHEK293 CellsHeLa CellsHumansImmunity, InnateMembrane ProteinsProtein BindingSignal TransductionTumor Necrosis Factor Receptor-Associated Peptides and ProteinsBacterial ProteinsMembrane ProteinsTRAF7 protein, humanTumor Necrosis Factor Receptor-Associated Peptides and ProteinsChlamydia trachomatishost-pathogen interactioninclusion membrane proteinmass spectrometryMEKK2MEKK3TRAF7WD40

Identifiers

PMID38814079
PMCPMC11218536

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.